Outcomes among confirmed cases and a matched comparison group in the Long-COVID in Scotland study

Claire E. Hastie; David J. Lowe; Andrew McAuley; Andrew J. Winter; Nicholas L. Mills; Corri Black; Janet T. Scott; Catherine A. O'Donnell; David N. Blane; Susan Browne; Tracy R. Ibbotson; Jill P. Pell

doi:10.1038/s41467-022-33415-5

Outcomes among confirmed cases and a matched comparison group in the Long-COVID in Scotland study

Claire E. Hastie, David J. Lowe, Andrew McAuley, Andrew J. Winter, Nicholas L. Mills, Corri Black, Janet T. Scott, Catherine A. O'Donnell, David N. Blane, Susan Browne, Tracy R. Ibbotson, Jill P. Pell^* (Corresponding Author)

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

22 Citations (Scopus)

Abstract

With increasing numbers infected by SARS-CoV-2, understanding long-COVID is essential to inform health and social care support. A Scottish population cohort of 33,281 laboratory-confirmed SARS-CoV-2 infections and 62,957 never-infected individuals were followed-up via 6, 12 and 18-month questionnaires and linkage to hospitalization and death records. Of the 31,486 symptomatic infections,1,856 (6%) had not recovered and 13,350 (42%) only partially. No recovery was associated with hospitalized infection, age, female sex, deprivation, respiratory disease, depression and multimorbidity. Previous symptomatic infection was associated with poorer quality of life, impairment across all daily activities and 24 persistent symptoms including breathlessness (OR 3.43, 95% CI 3.29-3.58), palpitations (OR 2.51, OR 2.36-2.66), chest pain (OR 2.09, 95% CI 1.96-2.23), and confusion (OR 2.92, 95% CI 2.78-3.07). Asymptomatic infection was not associated with adverse outcomes. Vaccination was associated with reduced risk of seven symptoms. Here we describe the nature of long-COVID and the factors associated with it.

In this population-based cohort study from Scotland, the authors investigate the prevalence of symptoms in the post-acute phase of COVID-19 infection compared to matched uninfected controls. They identify persistent symptoms associated with infection and identify factors associated with failure to recover.

Original language	English
Article number	5663
Number of pages	9
Journal	Nature Communications
Volume	13
Issue number	1
Early online date	12 Oct 2022
DOIs	https://doi.org/10.1038/s41467-022-33415-5
Publication status	Published - 12 Oct 2022

Keywords

Epidemiology
Risk factors
SARS-Cov-2

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1038/s41467-022-33415-5Licence: CC BY

Hastie_etal_NC_Outcomes_Among_COnfirmed_VoR
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
Final published version, 565 KBLicence: CC BY

Cite this

@article{078b3ceb7cc34d11b1da175d7ce354f8,

title = "Outcomes among confirmed cases and a matched comparison group in the Long-COVID in Scotland study",

abstract = "With increasing numbers infected by SARS-CoV-2, understanding long-COVID is essential to inform health and social care support. A Scottish population cohort of 33,281 laboratory-confirmed SARS-CoV-2 infections and 62,957 never-infected individuals were followed-up via 6, 12 and 18-month questionnaires and linkage to hospitalization and death records. Of the 31,486 symptomatic infections,1,856 (6%) had not recovered and 13,350 (42%) only partially. No recovery was associated with hospitalized infection, age, female sex, deprivation, respiratory disease, depression and multimorbidity. Previous symptomatic infection was associated with poorer quality of life, impairment across all daily activities and 24 persistent symptoms including breathlessness (OR 3.43, 95% CI 3.29-3.58), palpitations (OR 2.51, OR 2.36-2.66), chest pain (OR 2.09, 95% CI 1.96-2.23), and confusion (OR 2.92, 95% CI 2.78-3.07). Asymptomatic infection was not associated with adverse outcomes. Vaccination was associated with reduced risk of seven symptoms. Here we describe the nature of long-COVID and the factors associated with it.In this population-based cohort study from Scotland, the authors investigate the prevalence of symptoms in the post-acute phase of COVID-19 infection compared to matched uninfected controls. They identify persistent symptoms associated with infection and identify factors associated with failure to recover.",

keywords = "Epidemiology, Risk factors, SARS-Cov-2",

author = "Hastie, {Claire E.} and Lowe, {David J.} and Andrew McAuley and Winter, {Andrew J.} and Mills, {Nicholas L.} and Corri Black and Scott, {Janet T.} and O'Donnell, {Catherine A.} and Blane, {David N.} and Susan Browne and Ibbotson, {Tracy R.} and Pell, {Jill P.}",

note = "Funding Information: Long-CISS was funded by the Chief Scientist Office (ref. COV/LTE/20/06) and Public Health Scotland. NLM is supported by a Chair Award (CH/F/21/90010), a Programme Grant (RG/20/10/34966) and a Research Excellence Award (RE/18/5/34216) from the British Heart Foundation. We are grateful to Public Health Scotland and HDR-UK for providing and linking secondary data, the National Safe Haven for providing a secure analytical environment, Storm-ID for administering invitations and data collection, the Scottish Government for supporting the study launch, and the University of Glasgow, College of Medical, Veterinary and Life Sciences PPIE (Patient and Public Involvement and Engagement) and COVID-19 PPIE groups for their contributions to study design and recruitment. Author Correction: Outcomes among confirmed cases and a matched comparison group in the Long-COVID in Scotland study Claire E. Hastie, David J. Lowe, Andrew McAuley, Andrew J. Winter, Nicholas L. Mills, Corri Black, Janet T. Scott, Catherine A. O{\textquoteright}Donnell, David N. Blane, Susan Browne, Tracy R. Ibbotson & Jill P. Pell Nature Communications volume 13, Article number: 6540 (2022) Correction to: Nature Communications https://doi.org/10.1038/s41467-022-33415-5, published online 12 October 2022 ",

year = "2022",

month = oct,

day = "12",

doi = "10.1038/s41467-022-33415-5",

language = "English",

volume = "13",

journal = "Nature Communications",

issn = "2041-1723",

publisher = "Nature Publishing Group",

number = "1",

}

TY - JOUR

T1 - Outcomes among confirmed cases and a matched comparison group in the Long-COVID in Scotland study

AU - Hastie, Claire E.

AU - Lowe, David J.

AU - McAuley, Andrew

AU - Winter, Andrew J.

AU - Mills, Nicholas L.

AU - Black, Corri

AU - Scott, Janet T.

AU - O'Donnell, Catherine A.

AU - Blane, David N.

AU - Browne, Susan

AU - Ibbotson, Tracy R.

AU - Pell, Jill P.

N1 - Funding Information: Long-CISS was funded by the Chief Scientist Office (ref. COV/LTE/20/06) and Public Health Scotland. NLM is supported by a Chair Award (CH/F/21/90010), a Programme Grant (RG/20/10/34966) and a Research Excellence Award (RE/18/5/34216) from the British Heart Foundation. We are grateful to Public Health Scotland and HDR-UK for providing and linking secondary data, the National Safe Haven for providing a secure analytical environment, Storm-ID for administering invitations and data collection, the Scottish Government for supporting the study launch, and the University of Glasgow, College of Medical, Veterinary and Life Sciences PPIE (Patient and Public Involvement and Engagement) and COVID-19 PPIE groups for their contributions to study design and recruitment. Author Correction: Outcomes among confirmed cases and a matched comparison group in the Long-COVID in Scotland study Claire E. Hastie, David J. Lowe, Andrew McAuley, Andrew J. Winter, Nicholas L. Mills, Corri Black, Janet T. Scott, Catherine A. O’Donnell, David N. Blane, Susan Browne, Tracy R. Ibbotson & Jill P. Pell Nature Communications volume 13, Article number: 6540 (2022) Correction to: Nature Communications https://doi.org/10.1038/s41467-022-33415-5, published online 12 October 2022

PY - 2022/10/12

Y1 - 2022/10/12

N2 - With increasing numbers infected by SARS-CoV-2, understanding long-COVID is essential to inform health and social care support. A Scottish population cohort of 33,281 laboratory-confirmed SARS-CoV-2 infections and 62,957 never-infected individuals were followed-up via 6, 12 and 18-month questionnaires and linkage to hospitalization and death records. Of the 31,486 symptomatic infections,1,856 (6%) had not recovered and 13,350 (42%) only partially. No recovery was associated with hospitalized infection, age, female sex, deprivation, respiratory disease, depression and multimorbidity. Previous symptomatic infection was associated with poorer quality of life, impairment across all daily activities and 24 persistent symptoms including breathlessness (OR 3.43, 95% CI 3.29-3.58), palpitations (OR 2.51, OR 2.36-2.66), chest pain (OR 2.09, 95% CI 1.96-2.23), and confusion (OR 2.92, 95% CI 2.78-3.07). Asymptomatic infection was not associated with adverse outcomes. Vaccination was associated with reduced risk of seven symptoms. Here we describe the nature of long-COVID and the factors associated with it.In this population-based cohort study from Scotland, the authors investigate the prevalence of symptoms in the post-acute phase of COVID-19 infection compared to matched uninfected controls. They identify persistent symptoms associated with infection and identify factors associated with failure to recover.

AB - With increasing numbers infected by SARS-CoV-2, understanding long-COVID is essential to inform health and social care support. A Scottish population cohort of 33,281 laboratory-confirmed SARS-CoV-2 infections and 62,957 never-infected individuals were followed-up via 6, 12 and 18-month questionnaires and linkage to hospitalization and death records. Of the 31,486 symptomatic infections,1,856 (6%) had not recovered and 13,350 (42%) only partially. No recovery was associated with hospitalized infection, age, female sex, deprivation, respiratory disease, depression and multimorbidity. Previous symptomatic infection was associated with poorer quality of life, impairment across all daily activities and 24 persistent symptoms including breathlessness (OR 3.43, 95% CI 3.29-3.58), palpitations (OR 2.51, OR 2.36-2.66), chest pain (OR 2.09, 95% CI 1.96-2.23), and confusion (OR 2.92, 95% CI 2.78-3.07). Asymptomatic infection was not associated with adverse outcomes. Vaccination was associated with reduced risk of seven symptoms. Here we describe the nature of long-COVID and the factors associated with it.In this population-based cohort study from Scotland, the authors investigate the prevalence of symptoms in the post-acute phase of COVID-19 infection compared to matched uninfected controls. They identify persistent symptoms associated with infection and identify factors associated with failure to recover.

KW - Epidemiology

KW - Risk factors

KW - SARS-Cov-2

UR - https://doi.org/10.1038/s41467-022-34344-z

U2 - 10.1038/s41467-022-33415-5

DO - 10.1038/s41467-022-33415-5

M3 - Article

C2 - 36224173

VL - 13

JO - Nature Communications

JF - Nature Communications

SN - 2041-1723

IS - 1

M1 - 5663

ER -

Outcomes among confirmed cases and a matched comparison group in the Long-COVID in Scotland study

Abstract

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this